These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16549744)

  • 1. Hearing loss in patients with vestibulotoxic reactions to gentamicin therapy.
    Dobie RA; Black FO; Pezsnecker SC; Stallings VL
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):253-7. PubMed ID: 16549744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological issues when comparing hearing thresholds of a group with population standards: the case of the ferry engineers.
    Dobie RA
    Ear Hear; 2006 Oct; 27(5):526-37. PubMed ID: 16957502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audiometric analysis of a Belgian family linked to the DFNA10 locus.
    Verstreken M; Declau F; Schatteman I; Van Velzen D; Verhoeven K; Van Camp G; Willems PJ; Kuhweide EW; Verhaert E; D'Haese P; Wuyts FL; Van de Heyning PH
    Am J Otol; 2000 Sep; 21(5):675-81. PubMed ID: 10993457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audiometric analyses confirm a cochlear component, disproportional to age, in stapedial otosclerosis.
    Topsakal V; Fransen E; Schmerber S; Declau F; Yung M; Gordts F; Van Camp G; Van de Heyning P
    Otol Neurotol; 2006 Sep; 27(6):781-7. PubMed ID: 16885785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic sudden sensorineural hearing loss in the only hearing ear: patient characteristics and hearing outcome.
    Stahl N; Cohen D
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):193-5. PubMed ID: 16490878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical findings and long-term hearing results in 3,050 stapedotomies for primary otosclerosis: a prospective study with the otology-neurotology database.
    Vincent R; Sperling NM; Oates J; Jindal M
    Otol Neurotol; 2006 Dec; 27(8 Suppl 2):S25-47. PubMed ID: 16985478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of hearing in patients with unilateral acoustic neuromas: the importance of the contralateral ear.
    Stipkovits EM; van Dijk JE; Graamans K
    Am J Otol; 1998 Nov; 19(6):834-9. PubMed ID: 9831164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between transducer type and low-frequency hearing loss for patients with ventilation tubes.
    Tokar-Prejna S; Meinzen-Derr J
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1063-7. PubMed ID: 16364457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences to hearing during the conservative management of vestibular schwannomas.
    Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
    Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.